Clinical and Experimental Pediatrics

Review Article

Endocrinology

Endocrine comorbidities of pediatric obesity

Jieun Lee, Jae Hyun Kim

Clin Exp Pediatr. 2021;64(12):619-627. Published online August 26, 2021

∙ Pediatric obesity can involve endocrine comorbidities such as prediabetes, type 2 diabetes, dyslipidemia, metabolic syndrome, polycystic ovary syndrome, and central precocious puberty.
∙ Prediabetes and type 2 diabetes in youth aged 10–19 years had a prevalence of 25.9% and 0.6% in 2013–2014, respectively.
∙ Dyslipidemia in Korean adolescents aged 10–18 years had a prevalence of 7.64% (total cholesterol ≥200 mg/dL), 6.09% (low-density lipoprotein cholesterol ≥130 mg/dL), 8.69% (triglyceride ≥150 mg/dL), and 12.52% (high-density lipoprotein cholesterol ≤40 mg/dL) in 2007–2018.
∙ Metabolic syndrome in Korean youth has a prevalence of 1.9%–14.7% in males and 1.7%–12.6% in females with wide variation in definitions.
∙ Appropriate comorbidity screening and management and/or specialist referral are necessary for obese children and adolescents.

DOI: https://doi.org/10.3345/cep.2021.00213

Cited By 26	Neurodevelopmental outcomes of preterm infants
Cited By 21	Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies
Cited By 20	Association of gut microbiota with obesity in children and adolescents
Cited By 19	Prevalence of anxiety, depression, and stress among parents of neonates admitted to neonatal intensive care unit: a systematic review and meta-analysis
Cited By 18	Nonalcoholic fatty liver disease and insulin resistance in children

Search